Cargando…
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)
BACKGROUND: The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study that evaluated the safety and efficacy of a three-dose pentavalent rotavirus vaccine (RV5) including its effect on healthcare utilization for rotavirus gastroenteritis (RVGE). The per-protocol (PP) analyses,...
Autores principales: | Itzler, Robbin, Koch, Gary, Matson, David O, Gothefors, Leif, Van Damme, Pierre, DiNubile, Mark J, Heaton, Penny M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905347/ https://www.ncbi.nlm.nih.gov/pubmed/20540778 http://dx.doi.org/10.1186/1471-2431-10-42 |
Ejemplares similares
-
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine()
por: Desai, Sajjad, et al.
Publicado: (2018) -
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
por: Kulkarni, Prasad S., et al.
Publicado: (2017) -
Cost effectiveness of a pentavalent rotavirus vaccine in Oman
por: Al Awaidy, Salah Thabit, et al.
Publicado: (2014) -
Reassortment of Human Rotavirus Gene Segments into G11 Rotavirus Strains
por: Matthijnssens, Jelle, et al.
Publicado: (2010) -
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
por: Valencia-Mendoza, Atanacio, et al.
Publicado: (2008)